Encompass Health (NYSE:EHC – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday.
A number of other brokerages also recently issued reports on EHC. Royal Bank of Canada boosted their price objective on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Truist Financial reiterated a “buy” rating and set a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Barclays boosted their price objective on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research note on Friday. Finally, KeyCorp boosted their price target on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $107.33.
Encompass Health Stock Performance
Encompass Health (NYSE:EHC – Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. On average, equities research analysts expect that Encompass Health will post 4.29 earnings per share for the current fiscal year.
Institutional Trading of Encompass Health
Several institutional investors and hedge funds have recently made changes to their positions in EHC. MassMutual Private Wealth & Trust FSB lifted its position in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after purchasing an additional 137 shares during the last quarter. UMB Bank n.a. lifted its position in shares of Encompass Health by 387.7% during the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after purchasing an additional 252 shares during the last quarter. V Square Quantitative Management LLC increased its stake in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after buying an additional 140 shares during the period. Avior Wealth Management LLC purchased a new position in shares of Encompass Health during the third quarter valued at $40,000. Finally, Tompkins Financial Corp purchased a new position in shares of Encompass Health during the fourth quarter valued at $46,000. 97.25% of the stock is currently owned by institutional investors.
Encompass Health Company Profile
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Recommended Stories
- Five stocks we like better than Encompass Health
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- The How and Why of Investing in Gold Stocks
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- What is the Nikkei 225 index?
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.